Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Editorial

    Editorial

    Web AdminBy Web AdminJuly 5, 2024Updated:July 6, 2024No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ian E. Cock1,2
    1Centre for Planetary Health and Food Security, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    2School of Natural Sciences, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    DOI: 10.5530/pc.2024.3.15

    ABSTRACT

    Dear Readers and Authors, 

    I am pleased to bring you Volume 14, Issue 3 of Pharmacognosy Communications. In this issue, we present an evaluation of the anti-bacterial activity of commercial products prepared using Eucalyptus major (Maiden) Blakely and Melaleuca alternifolia (Maiden and Betche) Cheel leaves. The products were screened for anti-bacterial activity against several bacterial pathogens, including Methicillin-Resistant S. aureus (MRSA) and some Extended-Spectrum Β-Lactamase (ESBL) producing bacterial strains. Notably, the Eucalyptus product was particularly potent, including against the antibiotic-resistant bacterial strains. That study also reported that the commercial products were Ian E. Cock1,2 1Centre for Planetary Health and Food Security, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA. 2School of Natural Sciences, Nathan Campus, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA. Correspondence: Ian E. Cock Editor-in-Chief 1Centre for Planetary Health and Food Security, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA. 2School of Environment and Science, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA. Email id: i.cock@griffith.edu.au Editorial Editor-in-Chief non-toxic, highlighting their potential for topical usage. Another study tested Taraxacum officinale (L.) Weber ex F.H. Wigg root extracts against some bacterial triggers of autoimmune inflammatory diseases and reported noteworthy activity. Additionally, the extracts were tested in combination with conventional antibiotics and multiple synergistic and additive interactions were noted. Another study also reports noteworthy activity for Anongessius latifolia (Roxb. ex DC.) Wall. ex Euill. and Perr. triggers of rheumatoid arthritis and multiple sclerosis. Additionally, the A. latifolia extracts also potentiated the antibacterial activity of tetracycline and chloramphenicol, potentially reactivating them towards resistant bacterial strains. Several other plant extracts were also screened in that study, although, generally with only low activity. Another study presented in this issue screened Nigella damascena L. seed extracts, and reported that the extracts were generally ineffective at inhibioting the growth of any of the bacteria tested.

    DOWNLOAD PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up